Human-Animal Chimeras and Dehumanization
By John H. Evans,
Oxford University Press Blog
| 10. 01. 2016
The US government recently announced that it was lifting its moratorium on funding certain experiments that use human stem cells to create animals that are partly human. At present scientists are only interested in creating entities with some human qualities, but which remain “mostly” animals. For example, some scientists want to create a chimeric pig with a human-enough heart to transplant into a human.
Distinguishing between humans and other animals is common in most cultures and is certainly central to Western intellectual and religious traditions, so the idea of a part-pig part-human is very unsettling to many people. Warnings about the dangers of mixing animals and humans are also a classic theme in Western culture with novels like the Island of Doctor Moreau by H.G. Wells.
We can all agree that the world is not ready for a talking pig, and there is clearly a dystopian novel waiting to written about the pig given human consciousness but without the ability to interact. Moreover, an entity with a human body but a pig brain, which would be useful for human transplants...
Related Articles
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...